Xeroform is used as an astringent, drying, and antiseptic agent for inflammatory skin diseases.
Composition
- active ingredient: bismuth tribromophenate;
- 1 polymer bottle with a nozzle contains 10 g of bismuth tribromophenolate (xeroform).
Contraindication
Increased individual sensitivity.
Adverse reactions
They were not noted.
If any adverse reactions occur, treatment should be discontinued and a doctor should be consulted.
Method of application
Applied externally. The powder is applied to the affected areas of the skin. The duration of treatment depends on the course of the disease and is determined individually by the doctor.
Application features
Do not allow the drug to get into the eyes.
Use during pregnancy or breastfeeding
There are no data on the use of the drug during pregnancy or breastfeeding, so the drug should be prescribed only when, in the opinion of the doctor, the expected benefit to the mother outweighs the potential risk to the fetus or child.
Children
The efficacy and safety of the drug in children have not been established. For this reason, its use is possible only under the supervision and prescription of a doctor.
Ability to influence reaction speed when driving vehicles or other mechanisms
No effect.
Overdose
Data is missing.
Interaction with other medicinal products and other types of interactions
Not installed.
Storage conditions
Store at a temperature not exceeding +30 °C in a place inaccessible to children.






